New SEC Chair, Bitcoin, xAI Supercomputer, UnitedHealth CEO murder, with Gavin Baker & Joe Lonsdale

This episode features a panel discussion with investors Gavin Baker and Joe Lonsdale examining major developments in markets, technology, and policy under the incoming Trump administration. The conversation opens with analysis of the Trump Bump phenomenon, exploring how deregulation focus and America's advantageous position are reshaping expectations across multiple sectors. A significant portion centers on President Trump's nomination of Paul Atkins as SEC Chair, replacing Gary Gensler. This shift represents a potentially transformative change for cryptocurrency and financial markets regulation. The panelists discuss what Atkins' appointment means for Bitcoin, digital assets, and broader market dynamics. The conversation then shifts to Michael Saylor's aggressive Bitcoin accumulation strategy through MicroStrategy, which has become a hotly traded position on Wall Street. The discussion explores whether this represents visionary investing or excessive leverage, with particular attention to convertible bond arbitrage opportunities that have emerged around the company. Defense technology and US-China AI competition receive substantial focus, with the panelists emphasizing how critical infrastructure and compute capacity will determine technological supremacy. A major portion of the episode examines xAI's ambitious expansion plans, specifically their massive GPU cluster expansion toward one million units. The discussion explores how this infrastructure buildout will enable testing of AI scaling laws through Grok 3 development and what this means for artificial intelligence advancement. The panelists analyze whether xAI can successfully execute this vision and what competitive advantages or challenges lie ahead. The episode concludes with discussion of the murder of UnitedHealth CEO Brian Thompson in New York City. While the incident itself is tragic, the panelists explore reactions and what the event might signal about tensions in the healthcare industry, insurance practices, and broader societal issues. Throughout the episode, the panelists offer insights from their venture capital and investment perspectives, examining how these developments create both opportunities and risks for investors and entrepreneurs. The discussion reflects themes of regulatory change, technological competition, market dynamics, and emerging risks in American business and policy.